Evidence map›Paper›PMID 35277520›Full record

ArticleSchizophrenia (Heidelberg, Germany)2022

Cortical thinning over two years after first-episode psychosis depends on age of onset.

Laura Pina-Camacho, Kenia Martinez, Covadonga M Diaz-Caneja, Gisela Mezquida, Manuel J Cuesta, Carmen Moreno, Silvia Amoretti, Ana González-Pinto, Celso Arango, Eduard Vieta and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 15 institutions in 4 countries.

Laura Pina-Camacho *Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain. lpina.iisgm@gmail.com.ORCID 0000-0003-1960-6443
Kenia Martinez *Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
Covadonga M Diaz-CanejaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID 0000-0001-8538-3175
Gisela MezquidaBarcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute; Department of Medicine, Institut de Neurociències, Universitat de Barcelona; CIBERSAM; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Manuel J CuestaPsychiatry Department, Complejo Hospitalario de Navarra, Pamplona, Spain Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Carmen MorenoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID 0000-0003-0541-4846
Silvia AmorettiBarcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute; Department of Medicine, Institut de Neurociències, Universitat de Barcelona; CIBERSAM; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.ORCID 0000-0001-6017-2734
Ana González-PintoDepartment of Psychiatry, School of Medicine, University Hospital of Alava-Santiago, CIBERSAM, University of the Basque Country, Vitoria-Gasteiz, Spain.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID 0000-0003-3382-4754
Eduard VietaBarcelona Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Josefina Castro-FornielesDepartment of Child and Adolescent Psychiatry and Psychology, Institut Clinic de Neurociències, 2017SGR881, Hospital Clínic Universitari, CIBERSAM, Barcelona, Spain.ORCID 0000-0003-0632-2687
Antonio LoboDepartment of Medicine and Psychiatry, Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBERSAM, Zaragoza, Spain.ORCID 0000-0002-9098-655X
David FraguasInstitute of Psychiatry and Mental Health, Hospital Clínico San Carlos, IdISSC, CIBERSAM, School of medicine, Universidad Complutense, Madrid, Spain.
Miguel BernardoBarcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute; Department of Medicine, Institut de Neurociències, Universitat de Barcelona; CIBERSAM; August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.ORCID 0000-0001-8748-6717
Joost Janssen *Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
Mara Parellada *Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
PEPs Group
Centro de Investigación Biomédica en Red de Salud Mental · ESHospital General Universitario Gregorio Marañón · ESUniversity of the Basque Country · ESNeurosciences Institute · USUniversidad de Oviedo · ESUniversitat Autònoma de Barcelona · ESBellvitge University Hospital · ESHospital Mare de Déu de la Mercè · ESParc Sanitari Sant Joan de Déu · ESResearch Institute Hospital 12 de Octubre · ESUniversidad de Zaragoza · ESComplejo Hospitalario de Navarra · ESHospital Clínico San Carlos · ESKing's College London · GBUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

First-episode psychosis (FEP) patients show structural brain abnormalities at the first episode. Whether the cortical changes that follow a FEP are progressive and whether age at onset modulates these changes remains unclear. This is a multicenter MRI study in a deeply phenotyped sample of 74 FEP patients with a wide age range at onset (15-35 years) and 64 neurotypical healthy controls (HC). All participants underwent two MRI scans with a 2-year follow-up interval. We computed the longitudinal percentage of change (PC) for cortical thickness (CT), surface area (CSA) and volume (CV) for frontal, temporal, parietal and occipital lobes. We used general linear models to assess group differences in PC as a function of age at FEP. We conducted post-hoc analyses for metrics where PC differed as a function of age at onset. We found a significant age-by-diagnosis interaction effect for PC of temporal lobe CT (d = 0.54; p = 002). In a post-hoc-analysis, adolescent-onset (≤19 y) FEP showed more severe longitudinal cortical thinning in the temporal lobe than adolescent HC. We did not find this difference in adult-onset FEP compared to adult HC. Our study suggests that, in individuals with psychosis, CT changes that follow the FEP are dependent on the age at first episode, with those with an earlier onset showing more pronounced cortical thinning in the temporal lobe.

Identifiers

PMID35277520
PMCPMC8917180
OpenAlexW4220874908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.